Reduced BCL2 and CCND1 mRNA expression in human cervical cancer HeLa cells treated with a combination of everolimus and paclitaxel

Reduced BCL2 and CCND1 mRNA expression in human cervical cancer HeLa cells treated with a combination of everolimus and paclitaxel

Aim of the study : Cervical cancer is the second most common malignancy in women worldwide. Everolimus displays direct effects on growth and proliferation of cancer cells via inhibition of mammalian target of rapamycin (mTOR) protein, which is known to be associated with drug resistance. In this stu...

Full description

Bibliographic Details
Main Authors: Akin Yilmaz, Ebru Alp, H. Ilke Onen, Sevda Menevse
Format: Article
Language:English
Published: Termedia Publishing House 2016-03-01
Series:Contemporary Oncology
Subjects:
everolimus
gene expression
HeLa cells
paclitaxel
unfolded protein response
GRP78
BCL2
CCND1
CASP2
Online Access:https://www.termedia.pl/Reduced-BCL2-and-CCND1-mRNA-expression-in-human-cervical-cancer-HeLa-cells-treated-with-a-combination-of-everolimus-and-paclitaxel,3,27107,1,1.html

Internet

https://www.termedia.pl/Reduced-BCL2-and-CCND1-mRNA-expression-in-human-cervical-cancer-HeLa-cells-treated-with-a-combination-of-everolimus-and-paclitaxel,3,27107,1,1.html

Similar Items